Lantheus收購Life Molecular Imaging的新型治療和診斷雙重靶向劑

快訊 · 06/27 19:05

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting Grpr for Prostate and Breast Cancers

Lantheus收購Life Molecular Imaging的新型治療和診斷雙重靶向劑Grpr，用於前列腺和乳腺癌的全球權利。